REAX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
REAX is not a good buy right now for an impatient trader. The stock is in a clear downtrend (bearish moving averages and weakening MACD), hedge funds are aggressively selling, and there are no near-term news catalysts. While the price is sitting just above key support (3.49) and could bounce short-term, the current tape favors further downside or choppy action rather than a clean upside breakout. If you want to take action now, the higher-probability move is to avoid new long entries until price reclaims at least the pivot (3.66) and momentum stabilizes.
Trend/Momentum: Bearish. SMA_200 > SMA_20 > SMA_5 confirms an established downtrend. MACD histogram is -0.026 (below zero) and negatively expanding, indicating downside momentum is strengthening. RSI: RSI_6 = 30.594, near oversold but still labeled neutral here—this can support a short-term bounce, but it is not a reversal signal by itself. Levels: Current price 3.51 is just above S1 = 3.491 (near-term support). If S1 breaks, next support is S2 = 3.39. Upside resistance is the pivot at 3.656, then R1 3.82. Quant pattern read: Similar-pattern projection implies weak near-term drift (next week expected -1.46%), aligning with the bearish trend.
Intellectia Proprietary Trading Signals
with RSI near oversold, which can trigger a reflex rally if support holds.
Technical downtrend: Bearish moving average stack and deteriorating MACD suggest sellers remain in control.
Flow/positioning risk: Hedge funds are selling heavily (selling amount increased 7652.27% QoQ), a strong negative signal.
No near-term news catalysts: No news in the last week to spark an event-driven reversal.
Profitability deterioration: 2025/Q3 net income worsened to -$447K (down 82.71% YoY) and EPS fell to 0 (down 100% YoY).
Latest quarter: 2025/Q3. Revenue increased to $44.857M (+40.20% YoY), showing strong top-line growth. However, profitability weakened: net income was -$0.447M (down 82.71% YoY) and EPS dropped to 0 (-100% YoY). Overall: strong growth but deteriorating earnings quality, which can cap near-term upside unless margins/earnings stabilize.
Recent trend: One notable update—on 2026-01-23, Freedom Capital initiated coverage with a Buy and a $4.70 price target. Wall Street pros: Asset-light model, proprietary technology, and growth trajectory provide leverage to a real-estate recovery. Wall Street cons (from the tape/data): Despite the bullish initiation, the stock’s price trend is bearish, hedge fund selling is heavy, and the latest quarter showed weaker profitability—factors that can overwhelm a single fresh Buy call in the near term. Politicians/influential figures: No recent congress trading data available in the last 90 days.
